Eric Mitchell, editorial director and editor-in-chief of The Blood-Horse, shares his thoughts on the state of racehorse medication reform.
The suit was filed in May 2012 with the case based on affidavits from a whistleblower and a veterinarian, who alleged a pattern of abuse spread across satellite farms from New York to Kentucky to Oklahoma.
Eric Mitchell shares his thoughts on the U.S. Trotting Association’s recent exit from the RMTC.
The genetic integrity of North American-bred horses doesn’t seem to have been affected by race-day medication.
What could a recent Texas ruling about registering horse-clones with the AQHA mean for Thoroughbred breeders?
Eric Mitchell, editor-in-chief of The Blood-Horse, shares his thoughts on racehorse welfare issues.
CHRB officials contested reports that the state has seen a spike in the number of sudden death cases.
California racing saw a sharp increase last year in the number of fatalities due to cardiac failures.
Eric Mitchell shares his thoughts on the recently completed Welfare and Safety of the Racehorse Summit.
Trainers managing Salix-free horses noted that none of them have shown signs of bleeding after races so far.
The book covers the twisting morass of equine regulatory law and tells a history of Thoroughbred racing.
Race-day Salix will not be allowed in listed stakes races for 2-year-old Thoroughbreds.
I’ll Have Another was retired from racing June 8, the day before he had a shot at the Triple Crown t
Salix is a medication used to prevent exercise-induced pulmonary hemorrhaging, also known as bleeding.
Efforts to eliminate race-day medication and a federal bill that aims to create a national standard for medication use in Thoroughbred racehorses were the key topics discussed at a recent Thoroughbred Owners and Breeders Association board meeting.
The relationship between the TRF and its key benefactor, the Paul Mellon Estate, withered over the past year.
Stay on top of the most recent Horse Health news with
© 2022 Copyright Statement dolor sit amet, consetetur sadipscing User Terms, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.
